Written by SmithRx September 19, 2023
With a forward-looking policy platform, Transparency-Rx embraces many of the anticipated changes to the industry under consideration in Congress and increasingly advanced by state policy makers. Core tenets being championed by Transparency-Rx includes:
At the federal level, policymakers have advanced more than 43 bills impacting both the commercial and public sector markets. Transparency-Rx is working with Democrats, Republicans and the Administration so the strongest PBM reform package is advanced, a distinction from larger competitors opposing reforms.
Stated LeAnn Boyd, PharmD, CEO of Liviniti, a leading member of the Transparency-Rx:
“Congress should know patients, employers, and plans can thrive in a transparent, competitive, and efficient PBM market. We embrace critical reforms to a costly and misaligned drug pricing market. In fact, most of these reforms are already reflected in the business and innovations of transparent PBMs.”
Transparency-Rx’s growing coalition represents over 14.5 million covered lives with operations, employers, patients, and plans in all 50 states. Founding members include:
In an industry that has opposed meaningful drug reform, Transparency-Rx seeks to inject common-sense, change and clarity into a complex environment.